| nr |
titel |
type |
| 1 |
American journal of pharmacogenomics, vol. 1, no. 1 (2001)
|
aflevering
|
| 2 |
American journal of pharmacogenomics, vol. 3, no. 1 (2003)
|
aflevering
|
| 3 |
American journal of pharmacogenomics, vol. 5, no. 1 (2005)
|
aflevering
|
| 4 |
American journal of pharmacogenomics, vol. 4, no. 1 (2004)
|
aflevering
|
| 5 |
American journal of pharmacogenomics, vol. 2, no. 1 (2012-8-21)
|
aflevering
|
| 6 |
American journal of pharmacogenomics, vol. 1, no. 2 (2001)
|
aflevering
|
| 7 |
American journal of pharmacogenomics, vol. 2, no. 2 (2002)
|
aflevering
|
| 8 |
American journal of pharmacogenomics, vol. 5, no. 2 (2005)
|
aflevering
|
| 9 |
American journal of pharmacogenomics, vol. 3, no. 2 (2003)
|
aflevering
|
| 10 |
American journal of pharmacogenomics, vol. 4, no. 2 (2004)
|
aflevering
|
| 11 |
American journal of pharmacogenomics, vol. 1, no. 3 (2012-8-21)
|
aflevering
|
| 12 |
American journal of pharmacogenomics, vol. 2, no. 3 (2002)
|
aflevering
|
| 13 |
American journal of pharmacogenomics, vol. 3, no. 3 (2003)
|
aflevering
|
| 14 |
American journal of pharmacogenomics, vol. 5, no. 3 (2005)
|
aflevering
|
| 15 |
American journal of pharmacogenomics, vol. 4, no. 3 (2012-8-21)
|
aflevering
|
| 16 |
American journal of pharmacogenomics, vol. 4, no. 4 (2004)
|
aflevering
|
| 17 |
American journal of pharmacogenomics, vol. 5, no. 4 (2005)
|
aflevering
|
| 18 |
American journal of pharmacogenomics, vol. 3, no. 4 (2003)
|
aflevering
|
| 19 |
American journal of pharmacogenomics, vol. 2, no. 4 (2012-9-8)
|
aflevering
|
| 20 |
American journal of pharmacogenomics, vol. 5, no. 5 (2005)
|
aflevering
|
| 21 |
American journal of pharmacogenomics, vol. 3, no. 5 (2003)
|
aflevering
|
| 22 |
American journal of pharmacogenomics, vol. 4, no. 5 (2012-8-21)
|
aflevering
|
| 23 |
American journal of pharmacogenomics, vol. 4, no. 6 (2004)
|
aflevering
|
| 24 |
American journal of pharmacogenomics, vol. 3, no. 6 (2003)
|
aflevering
|
Tijdschrift beschrijving